I Mahmood

发表

Impact of random and fixed (optimal) sampling approach on the Bayesian estimation of clearance.

I Mahmood, 2003, International journal of clinical pharmacology and therapeutics.

Interspecies Scaling: Predicting Volumes, Mean Residence Time and Elimination Half‐life. * Some Suggestions

I Mahmood, I. Mahmood, 1998, The Journal of pharmacy and pharmacology.

Interspecies scaling of renally secreted drugs.

I Mahmood, I. Mahmood, 1998, Life sciences.

Interspecies allometric scaling. Part I: prediction of clearance in large animals.

I Mahmood, I. Mahmood, M Martinez, 2006, Journal of veterinary pharmacology and therapeutics.

Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.

I Mahmood, I. Mahmood, M Martinez, 2006, Journal of veterinary pharmacology and therapeutics.

Comparison of different reduced sampling approaches for the estimation of pharmacokinetic parameters for long half-life drugs in patients with renal or hepatic impairment.

I Mahmood, 2002, International journal of clinical pharmacology and therapeutics.

Does percent reduction in seizure frequency correlate with plasma concentration of anticonvulsant drugs? Experience with four anticonvulsant drugs

I Mahmood, I. Mahmood, V K Tammara, 1998, Clinical pharmacology and therapeutics.

Allometric issues in drug development.

I Mahmood, I. Mahmood, 1999, Journal of pharmaceutical sciences.

Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: a computer simulation analysis.

I Mahmood, R. Miller, I. Mahmood, 1999, International journal of clinical pharmacology and therapeutics.

The Pharmacokinetic Principles Behind Scaling from Preclinical Results to Phase I Protocols

I Mahmood, J. Balian, I. Mahmood, 1999, Clinical pharmacokinetics.

Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.

I Mahmood, J. Balian, I. Mahmood, 1996, Journal of pharmaceutical sciences.

Application of Preclinical Data to Initiate the Modified Continual Reassessment Method for Maximum Tolerated Dose—Finding Trials

I Mahmood, 2001, Journal of clinical pharmacology.